CSIMarket
 


Vystar Corporation  (VYST)
Other Ticker:  
 
 

VYST's Operating Income Growth by Quarter and Year

Vystar's Operating Income results by quarter and year




VYST Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -2.37 -0.54 -0.75
III Quarter September -0.80 -1.55 -2.17 -1.21
II Quarter June -1.09 -1.44 -1.04 -0.98
I Quarter March -0.87 0.97 -0.85 -2.00
FY   -2.76 -4.39 -4.60 -4.94



VYST Operating Income third quarter 2022 Y/Y Growth Comment
Vystar Corporation in the third quarter 2022 recorded Operating Loss of $ -0.80 millions.

According to the results reported in the third quarter 2022, Vystar Corporation achieved the best Operating Income growth in Medical Equipment & Supplies industry. While Vystar Corporation' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


VYST Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vystar's third quarter 2022 Operating Income $ -0.80 millions VYST's Income Statement
Vystar's third quarter 2021 Operating Income $ -1.55 millions Quarterly VYST's Income Statement
New: More VYST's historic Operating Income Growth >>


VYST Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Vystar's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VYST's III. Quarter Q/Q Operating Income Comment
Although Vystar Corporation in the III. Quarter 2022 revealed Operating Loss of $ -0.80 millions, it should be said, that current results are improvement in contrast to the -1.09 millions in the second quarter.

Within Medical Equipment & Supplies industry Vystar Corporation achieved highest sequential Operating Income growth. While Vystar's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VYST's III. Quarter Q/Q Operating Income Comment
Although Vystar Corporation in the III. Quarter 2022 showed Operating Loss of $ -0.80 millions, it should be said, that current results are recovery in contrast to the -1.09 millions in the second quarter.

Within Medical Equipment & Supplies industry Vystar Corporation achieved highest sequential Operating Income growth. While Vystar's Operating Income growth quarter on quarter, overall rank is .


Vystar's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -5.12 $ -5.88 $ -6.22 $ -4.39 $ -2.56
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Vystar Corporation' has realized cumulative trailing twelve months Operating Loss of $ -5 millions in the Sep 30 2022 period.

Vystar Corporation achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Vystar Corporation' has realized cumulative trailing twelve months Operating Loss of $ -5 millions in the Sep 30 2022 period.

Vystar Corporation achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
VYST's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for VYST's Competitors
Operating Income Growth for Vystar's Suppliers
Operating Income Growth for VYST's Customers

You may also want to know
VYST's Annual Growth Rates VYST's Profitability Ratios VYST's Asset Turnover Ratio VYST's Dividend Growth
VYST's Roe VYST's Valuation Ratios VYST's Financial Strength Ratios VYST's Dividend Payout Ratio
VYST's Roa VYST's Inventory Turnover Ratio VYST's Growth Rates VYST's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Zoetis Inc -0.28%$ -0.278 millions
Charles River Laboratories International inc -3.10%$ -3.098 millions
Sotera Health Company-3.77%$ -3.770 millions
Encompass Health Corporation-3.92%$ -3.919 millions
Abiomed Inc -4.04%$ -4.041 millions
Owens and Minor inc-4.18%$ -4.180 millions
Amphastar Pharmaceuticals Inc -6.22%$ -6.221 millions
Phibro Animal Health Corporation-6.35%$ -6.351 millions
Boston Scientific Corporation-7.49%$ -7.494 millions
Conmed Corporation-9.22%$ -9.221 millions
Intuitive Surgical Inc -9.87%$ -9.873 millions
Cadre Holdings Inc -10.60%$ -10.605 millions
Eli Lilly And Company-10.88%$ -10.881 millions
Bio techne Corp-10.92%$ -10.922 millions
Corcept Therapeutics Inc-11.86%$ -11.862 millions
U S Physical Therapy Inc-12.03%$ -12.030 millions
Universal Health Services Inc -12.37%$ -12.366 millions
Semler Scientific Inc -14.96%$ -14.963 millions
National Research Corporation-15.44%$ -15.444 millions
Lhc Group Inc -15.76%$ -15.758 millions
Merck and Co Inc -16.69%$ -16.694 millions
Zynex inc -18.49%$ -18.494 millions
Pediatrix Medical Group Inc -19.40%$ -19.400 millions
Molecular Templates inc -19.85%$ -19.852 millions
Kintara Therapeutics Inc -22.19%$ -22.191 millions
Tenax Therapeutics Inc -23.27%$ -23.270 millions
Alpha Pro Tech Ltd -23.79%$ -23.793 millions
Elite Pharmaceuticals Inc -24.00%$ -24.003 millions
Maravai Lifesciences Holdings Inc -25.48%$ -25.479 millions
Gilead Sciences Inc -26.16%$ -26.158 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com